HFCAS OpenIR
Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck
Xu, Qiang1,2; Fang, Meiyu2,3; Zhu, Jing2,4; Dong, Haoru5; Cao, Jun2,3; Yan, Lin6; Leonard, Fransisca7; Oppel, Felix8; Sudhoff, Holger8; Kaufmann, Andreas M.9,10,11,12; Albers, Andreas E.10,11,12,13; Qian, Xu2,4
2020
发表期刊INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
ISSN1449-2288
通讯作者Qian, Xu(qian_michelle2014@163.com)
摘要Immunotherapies such as immune checkpoint blockade benefit only a portion of patients with head and neck squamous cell carcinoma. The multidisciplinary field of nanomedicine is emerging as a promising strategy to achieve maximal anti-tumor effect in cancer immunotherapy and to turn non-responders into responders. Various methods have been developed to deliver therapeutic agents that can overcome bio-barriers, improve therapeutic delivery into the tumor and lymphoid tissues and reduce adverse effects in normal tissues. Additional modification strategies also have been employed to improve targeting and boost cytotoxic T cell-based immune responses. Here, we review the state-of-the-art use of nanotechnologies in the laboratory, in advanced preclinical phases as well as those running through clinical trials assessing their advantages and challenges.
关键词nanotherapeutics drug delivery cancer immunotherapy nanovaccine head and neck squamous cell carcinoma human papillomavirus
DOI10.7150/ijbs.47068
关键词[WOS]NANOPARTICLE VACCINE ; NAB-PACLITAXEL ; OPEN-LABEL ; CANCER ; DELIVERY ; EFFICACY ; PEPTIDE ; POTENT ; DNA ; CISPLATIN
收录类别SCI
语种英语
资助项目National Natural Science Foundation of China[81702091] ; Medical and the Health Science Project of Zhejiang Province[2019KY327] ; Guangji Talents Foundation Award (E) of Zhejiang Cancer Hospital
项目资助者National Natural Science Foundation of China ; Medical and the Health Science Project of Zhejiang Province ; Guangji Talents Foundation Award (E) of Zhejiang Cancer Hospital
WOS研究方向Biochemistry & Molecular Biology ; Life Sciences & Biomedicine - Other Topics
WOS类目Biochemistry & Molecular Biology ; Biology
WOS记录号WOS:000555111400003
出版者IVYSPRING INT PUBL
引用统计
被引频次:10[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.hfcas.ac.cn:8080/handle/334002/45143
专题中国科学院合肥物质科学研究院
通讯作者Qian, Xu
作者单位1.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Peoples R China
2.Chinese Acad Sci, Inst Canc & Basic Med IBMC, Hangzhou, Peoples R China
3.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Key Lab Head & Neck Canc Translat Res Zhejiang Pr, Hangzhou, Peoples R China
4.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Dept Clin Lab, Hangzhou, Peoples R China
5.Wenzhou Med Univ, Sch Clin Med 1, Wenzhou, Peoples R China
6.Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China
7.Houston Methodist Res Inst, Dept Nanomed, Houston, TX USA
8.Klinikum Bielefeld, Dept Otolaryngol Head & Neck Surg, Bielefeld, Germany
9.Charite Univ Med Berlin, Clin Gynecol, Berlin, Germany
10.Free Univ Berlin, Berlin, Germany
11.Humboldt Univ, Berlin, Germany
12.Berlin Inst Hlth, Berlin, Germany
13.Charite Univ Med Berlin, Dept Otolaryngol Head & Neck Surg, Berlin, Germany
推荐引用方式
GB/T 7714
Xu, Qiang,Fang, Meiyu,Zhu, Jing,et al. Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck[J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES,2020,16.
APA Xu, Qiang.,Fang, Meiyu.,Zhu, Jing.,Dong, Haoru.,Cao, Jun.,...&Qian, Xu.(2020).Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck.INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES,16.
MLA Xu, Qiang,et al."Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck".INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES 16(2020).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Xu, Qiang]的文章
[Fang, Meiyu]的文章
[Zhu, Jing]的文章
百度学术
百度学术中相似的文章
[Xu, Qiang]的文章
[Fang, Meiyu]的文章
[Zhu, Jing]的文章
必应学术
必应学术中相似的文章
[Xu, Qiang]的文章
[Fang, Meiyu]的文章
[Zhu, Jing]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。